Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke: Clinical Outcomes from a Phase I Safety Study

Stroke is a major cause of death and long‐term disability, affecting one in six people worldwide. The only currently available approved pharmacological treatment for ischemic stroke is tissue plasminogen activator; however, relatively few patients are eligible for this therapy. We hypothesized that...

Descripción completa

Detalles Bibliográficos
Autores principales: Laskowitz, Daniel T., Bennett, Ellen R., Durham, Rebecca J., Volpi, John J., Wiese, Jonathan R., Frankel, Michael, Shpall, Elizabeth, Wilson, Jeffry M., Troy, Jesse, Kurtzberg, Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Translational Research Articles and Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052613/
https://www.ncbi.nlm.nih.gov/pubmed/29752869
http://dx.doi.org/10.1002/sctm.18-0008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052613/
https://www.ncbi.nlm.nih.gov/pubmed/29752869
http://dx.doi.org/10.1002/sctm.18-0008

Ejemplares similares